Ensign Peak Advisors, Inc Dexcom Inc Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Dexcom Inc stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 278,313 shares of DXCM stock, worth $22.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

278,313

Previous 310,746 10.44%

Holding current value

$22.3 Million

Previous $35.2 Million 47.06%

% of portfolio

0.03%

Previous 0.07%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $2.08 Million - $3.76 Million	-32,433 Reduced 10.44%	278,313 $18.7 Million
Q2 2024 Aug 13, 2024	SELL	$110.31 - $140.45 $2.99 Million - $3.8 Million	-27,067 Reduced 8.01%	310,746 $35.2 Million
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $80.2 Million - $98.4 Million	-702,387 Reduced 67.52%	337,813 $46.9 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $27.3 Million - $44.9 Million	361,530 Added 53.27%	1,040,200 $129 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $36.6 Million - $58.6 Million	424,979 Added 167.52%	678,670 $63.3 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $7.42 Million - $8.64 Million	66,001 Added 35.16%	253,691 $32.6 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $356,408 - $421,246	3,427 Added 1.86%	187,690 $21.8 Million
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $7.13 Million - $10.3 Million	83,884 Added 83.57%	184,263 $20.9 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $3.75 Million - $4.63 Million	-49,135 Reduced 32.86%	100,379 $8.09 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $7.54 Million - $14.7 Million	110,899 Added 287.19%	149,514 $11.1 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $3.01 Million - $4.16 Million	-31,968 Reduced 45.29%	38,615 $19.8 Million
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $242,986 - $304,636	1,871 Added 2.72%	70,583 $37.9 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $530,241 - $711,461	4,969 Added 7.8%	68,712 $37.6 Million
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $58,393 - $77,817	721 Added 1.14%	63,743 $27.2 Million
Q1 2021 May 12, 2021	BUY	$84.79 - $104.74 $615,490 - $760,307	7,259 Added 13.02%	63,022 $22.6 Million
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $2.83 Million - $3.79 Million	36,240 Added 185.63%	55,763 $20.6 Million
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $476,690 - $563,733	4,991 Added 34.34%	19,523 $8.05 Million
Q2 2020 Aug 12, 2020	BUY	$62.68 - $105.34 $869,622 - $1.46 Million	13,874 Added 2108.51%	14,532 $5.89 Million
Q1 2020 May 11, 2020	SELL	$47.79 - $75.63 $171,661 - $271,662	-3,592 Reduced 84.52%	658 $177,000
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $155,635 - $243,482	4,250 New	4,250 $930,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Dexcom Inc Transaction History